| Product Information |
|
| Registration Number |
BR-1462
|
| Generic Name |
Ocrelizumab
|
| Brand Name |
Ocrevus
|
| Dosage Strength |
300 mg/10 ml (30 mg/ml)
|
| Dosage Form |
Concentrate for Solution for
Intravenous Infusion.
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Selective Immunosuppresant
|
| Packaging |
15 mL colorless USP/Ph. Eur./JP Type I glass vial with a 20 mm rubber stopper laminated with fluororesin film, which is crimped with a 20 mm aluminum seal fitted with a plastic flip-off cap
|
| Manufacturer |
Roche Diagnostics GmbH
|
| Country of Origin |
Germany
|
| Trader |
|
| Importer |
Roche (Philippines), Inc.
|
| Distributor |
|
| Application Type |
Monitored Release
|
| Issuance Date |
22 December 2023
|
| Expiry Date |
22 December 2028
|